| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,633,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,434,166 |
Avg
Vol: |
650,831 |
| 52
Week Range: |
$21.74 - $21.74 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-27 |
4 |
S |
$15.73 |
$47,190 |
D/D |
(3,000) |
34,838 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-27 |
4 |
OE |
$9.34 |
$28,020 |
D/D |
3,000 |
37,838 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-25 |
4 |
S |
$15.19 |
$37,975 |
D/D |
(2,500) |
34,838 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-25 |
4 |
OE |
$2.93 |
$7,325 |
D/D |
2,500 |
37,338 |
|
- |
|
| Nolan Michael M |
VP, CFO and Treasurer |
• – – |
2014-02-24 |
4 |
S |
$15.00 |
$225,000 |
D/D |
(15,000) |
76,093 |
|
- |
|
| Nolan Michael M |
VP, CFO and Treasurer |
• – – |
2014-02-24 |
4 |
OE |
$3.43 |
$51,450 |
D/D |
15,000 |
91,093 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-21 |
4 |
S |
$14.87 |
$22,305 |
D/D |
(1,500) |
34,838 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-19 |
4 |
S |
$13.37 |
$20,055 |
D/D |
(1,500) |
36,338 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,038) |
37,838 |
|
- |
|
| Henderson Lori M |
VP, Secretary & Gen. Counsel |
• – – |
2014-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,038) |
58,997 |
|
- |
|
| Cable Stuart M |
10% Owner |
– – • |
2014-02-13 |
4 |
AS |
$12.00 |
$360,000 |
I/I |
(30,000) |
4,353,289 |
|
- |
|
| Marth William S |
President and CEO |
• • – |
2014-02-04 |
4 |
A |
$10.50 |
$999,999 |
D/D |
95,238 |
283,699 |
|
- |
|
| Henderson Lori M |
VP, Secretary & Gen. Counsel |
• – – |
2014-02-04 |
4 |
A |
$10.43 |
$152,111 |
D/D |
14,584 |
60,035 |
|
- |
|
| Henderson Lori M |
VP, Secretary & Gen. Counsel |
• – – |
2014-02-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(948) |
45,451 |
|
- |
|
| Roth Arthur J |
Director |
– • – |
2014-02-04 |
4 |
A |
$10.43 |
$35,003 |
D/D |
3,356 |
36,856 |
|
- |
|
| Ryan Una S |
Director |
– • – |
2014-02-04 |
4 |
A |
$10.43 |
$35,003 |
D/D |
3,356 |
30,874 |
|
- |
|
| Oconnor Kevin |
Director |
– • – |
2014-02-04 |
4 |
A |
$10.43 |
$35,003 |
D/D |
3,356 |
35,210 |
|
- |
|
| Nolan Michael M |
VP, CFO and Treasurer |
• – – |
2014-02-04 |
4 |
A |
$10.43 |
$173,826 |
D/D |
16,666 |
76,093 |
|
- |
|
| Leung Gabriel |
Director |
– • – |
2014-02-04 |
4 |
A |
$10.43 |
$35,003 |
D/D |
3,356 |
28,677 |
|
- |
|
| Hagen Steven R |
Sr VP Pharmaceutical Dev & Mfg |
• – – |
2014-02-04 |
4 |
A |
$10.43 |
$130,375 |
D/D |
12,500 |
38,876 |
|
- |
|
| Svokos George |
Sr. VP Sales & GM of API |
• – – |
2014-02-04 |
4 |
A |
$10.43 |
$152,111 |
D/D |
14,584 |
44,584 |
|
- |
|
| Luther Michael A |
Senior VP, Discovery Services |
• – – |
2014-02-04 |
4 |
A |
$10.43 |
$130,375 |
D/D |
12,500 |
32,500 |
|
- |
|
| D Ambra Thomas E Phd |
Chairman, Board of Directors |
– • – |
2014-02-04 |
4 |
A |
$10.43 |
$35,003 |
D/D |
3,356 |
2,848,546 |
|
- |
|
| Jordan Veronica Gh |
Director |
– • – |
2014-02-04 |
4 |
A |
$10.43 |
$35,003 |
D/D |
3,356 |
33,937 |
|
- |
|
| Nolan Michael M |
VP, CFO and Treasurer |
• – – |
2014-01-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,384) |
59,427 |
|
- |
|
620 Records found
|
|
Page 13 of 25 |
|
|
